FATE Market Cap & Key Metrics
Fate Therapeutics, Inc.
$1.94
-$0.06(-3.00%)
40
Overall
60
Value
20
Tech
42
Quality
Market Cap
$232.45M
Volume
1.67M
52W Range
$0.95 - $3.23
Target Price
$5.74
FATE market cap is $232.45M. This page lists Fate Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
FATE Key Metrics
- Market cap
- $232.45M
- EPS estimate, current year
- $-1.03
- EPS growth, 3-year
- +26.62%
- Value score
- 60
- Quality score
- 42
- Technical score
- 20
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $6.65M | $13.63M | $63.53M | $96.30M | $55.85M |
| EBITDA | -$123.42M | -$167.26M | -$147.48M | -$294.63M | -$211.14M |
| EPS | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.94 | -3.0% | 1.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |